April 2009
Opinion: Supreme Court Botches Preemption Case
Statement on Wyeth v. Levine
By Gregory Conko
The Supreme Court handed down its decision last month in the case of Wyeth v. Levine, ruling that federal law did not bar plaintiff Diana Levine from suing pharmaceutical maker Wyeth over allegedly insufficient drug safety warnings, even though the warnings had been approved by the Food and Drug Administration (FDA). This decision establishes the troubling precedent that a sympathetic jury can now supersede the expert opinions of the FDA on what qualifies as adequate safety labeling.
Log In
Subscribers: Log in below to read the full story
Already subscribe but haven't registered for all the benefits of the website?
Subscribe
Click below to subscribe to
PRODUCT LIABILITY LAW & STRATEGY
Pay-Per-View
You can purchase this article for $20.00
Click below
Follow us